Loading...
Header Logo
Keywords
Last Name
Institution

MARTA PENAS-PRADO

TitleAssistant Professor
InstitutionMD Anderson
DepartmentNeuro-Oncology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Harrison RA, Anderson MD, Cachia D, Kamiya-Matsuoka C, Weathers SS, O'Brien BJ, Penas-Prado M, Yung WKA, Wu J, Yuan Y, de Groot JF. Clinical trial participation of patients with glioblastoma at The University of Texas MD Anderson Cancer Center. Eur J Cancer. 2019 May; 112:83-93. PMID: 30951926.
      View in: PubMed
    2. Cavaletti G, Cornblath DR, Merkies ISJ, Postma TJ, Rossi E, Alberti P, Bruna J, Argyriou AA, Briani C, Velasco R, Kalofonos HP, Psimaras D, Ricard D, Pace A, Faber CG, Lalisang RI, Brandsma D, Koeppen S, Kerrigan S, Schenone A, Grisold W, Mazzeo A, Padua L, Dorsey SG, Penas-Prado M, Valsecchi MG. Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity. J Peripher Nerv Syst. 2019 Mar; 24(1):111-119. PMID: 30672664.
      View in: PubMed
    3. Maraka S, Groves MD, Penas-Prado M. Reply to Unexpectedly low rates of neuropsychiatric adverse effects associated with mefloquine repurposed for the treatment of glioblastoma. Cancer. 2019 Apr 15; 125(8):1385-1386. PMID: 30707757.
      View in: PubMed
    4. Majd NK, Metrus NR, Santos-Pinheiro F, Trevino CR, Fuller GN, Huse JT, Chung C, Ketonen L, Anderson MD, Penas-Prado M. RBM10 truncation in astroblastoma in a patient with history of mandibular ameloblastoma: A case report. Cancer Genet. 2019 Feb; 231-232:41-45. PMID: 30803556.
      View in: PubMed
    5. Lassman AB, van den Bent MJ, Gan HK, Reardon DA, Kumthekar P, Butowski N, Lwin Z, Mikkelsen T, Nabors LB, Papadopoulos KP, Penas-Prado M, Simes J, Wheeler H, Walbert T, Scott AM, Gomez E, Lee HJ, Roberts-Rapp L, Xiong H, Ansell PJ, Bain E, Holen KD, Maag D, Merrell R. Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial. Neuro Oncol. 2019 Jan 01; 21(1):106-114. PMID: 29982805.
      View in: PubMed
    6. Yeboa DN, Yu JB, Liao E, Huse J, Penas-Prado M, Kann BH, Sulman E, Grosshans D, Contessa J. Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas. Clin Transl Radiat Oncol. 2019 Feb; 15:46-52. PMID: 30656222.
      View in: PubMed
    7. Harrison RA, Kesler SR, Johnson JM, Penas-Prado M, Sullaway CM, Wefel JS. Neurocognitive dysfunction in adult cerebellar medulloblastoma. Psychooncology. 2019 Jan; 28(1):131-138. PMID: 30315720.
      View in: PubMed
    8. Maraka S, Groves MD, Mammoser AG, Melguizo-Gavilanes I, Conrad CA, Tremont-Lukats IW, Loghin ME, O'Brien BJ, Puduvalli VK, Sulman EP, Hess KR, Aldape KD, Gilbert MR, de Groot JF, Alfred Yung WK, Penas-Prado M. Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma. Cancer. 2019 Feb 01; 125(3):424-433. PMID: 30359477.
      View in: PubMed
    9. Ileana Dumbrava E, Smith V, Alfattal R, El-Naggar AK, Penas-Prado M, Tsimberidou AM. Autoimmune Granulomatous Inflammation of Lacrimal Glands and Axonal Neuritis Following Treatment With Ipilimumab and Radiation Therapy. J Immunother. 2018 09; 41(7):336-339. PMID: 29787423.
      View in: PubMed
    10. Machol K, Jankovic J, Vijayakumar D, Burrage LC, Jain M, Lewis RA, Fuller GN, Xu M, Penas-Prado M, Gule-Monroe MK, Rosenfeld JA, Chen R, Eng CM, Yang Y, Lee BH, Moretti PM, Dhar SU. Atypical Alexander disease with dystonia, retinopathy, and a brain mass mimicking astrocytoma. Neurol Genet. 2018 Aug; 4(4):e248. PMID: 30046660.
      View in: PubMed
    11. Hashimoto Y, Penas-Prado M, Zhou S, Wei J, Khatua S, Hodges TR, Sanai N, Xiu J, Gatalica Z, Kim L, Kesari S, Rao G, Spetzler D, Heimberger A. Rethinking medulloblastoma from a targeted therapeutics perspective. J Neurooncol. 2018 Sep; 139(3):713-720. PMID: 29869738.
      View in: PubMed
    12. Ballester LY, Penas-Prado M, Leeds NE, Huse JT, Fuller GN. FGFR1 tyrosine kinase domain duplication in pilocytic astrocytoma with anaplasia. Cold Spring Harb Mol Case Stud. 2018 04; 4(2). PMID: 29610389.
      View in: PubMed
    13. Ali AN, Zhang P, Yung WKA, Chen Y, Movsas B, Urtasun RC, Jones CU, Choi KN, Michalski JM, Fischbach AJ, Markoe AM, Schultz CJ, Penas-Prado M, Garg MK, Hartford AC, Kim HE, Won M, Curran WJ. NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients. J Neurooncol. 2018 Mar; 137(1):39-47. PMID: 29404979.
      View in: PubMed
    14. van den Bent M, Gan HK, Lassman AB, Kumthekar P, Merrell R, Butowski N, Lwin Z, Mikkelsen T, Nabors LB, Papadopoulos KP, Penas-Prado M, Simes J, Wheeler H, Walbert T, Scott AM, Gomez E, Lee HJ, Roberts-Rapp L, Xiong H, Bain E, Ansell PJ, Holen KD, Maag D, Reardon DA. Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study. Cancer Chemother Pharmacol. 2017 Dec; 80(6):1209-1217. PMID: 29075855.
      View in: PubMed
    15. Penas-Prado M, de Groot J. CATNON interim results: another triumph of upfront chemotherapy in glioma. Neuro Oncol. 2017 Oct 01; 19(10):1287-1288. PMID: 28922864.
      View in: PubMed
    16. Gittleman H, Lim D, Kattan MW, Chakravarti A, Gilbert MR, Lassman AB, Lo SS, Machtay M, Sloan AE, Sulman EP, Tian D, Vogelbaum MA, Wang TJC, Penas-Prado M, Youssef E, Blumenthal DT, Zhang P, Mehta MP, Barnholtz-Sloan JS. An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825. Neuro Oncol. 2017 05 01; 19(5):669-677. PMID: 28453749.
      View in: PubMed
    17. Chang S, Zhang P, Cairncross JG, Gilbert MR, Bahary JP, Dolinskas CA, Chakravarti A, Aldape KD, Bell EH, Schiff D, Jaeckle K, Brown PD, Barger GR, Werner-Wasik M, Shih H, Brachman D, Penas-Prado M, Robins HI, Belanger K, Schultz C, Hunter G, Mehta M. Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813. Neuro Oncol. 2017 02 01; 19(2):252-258. PMID: 27994066.
      View in: PubMed
    18. Penas-Prado M. Practice-Changing Abstracts From the 2016 Society for Neuro-Oncology Annual Scientific Meeting. Am Soc Clin Oncol Educ Book. 2017; 37:187-191. PMID: 28561706.
      View in: PubMed
    19. Gilbert MR, Pugh SL, Aldape K, Sorensen AG, Mikkelsen T, Penas-Prado M, Bokstein F, Kwok Y, Lee RJ, Mehta M. NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma. J Neurooncol. 2017 01; 131(1):193-199. PMID: 27770279.
      View in: PubMed
    20. Kamiya-Matsuoka C, Cachia D, Waguespack SG, Crane CH, Mahajan A, Brown PD, Nam JY, McCutcheon IE, Penas-Prado M. Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma. Pituitary. 2016 Aug; 19(4):415-21. PMID: 27106209.
      View in: PubMed
    21. Weathers SP, Han X, Liu DD, Conrad CA, Gilbert MR, Loghin ME, O'Brien BJ, Penas-Prado M, Puduvalli VK, Tremont-Lukats I, Colen RR, Yung WKA, de Groot JF. A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma. J Neurooncol. 2016 09; 129(3):487-494. PMID: 27406589.
      View in: PubMed
    22. Strickland BA, Cachia D, Jalali A, Cykowski MD, Penas-Prado M, Langford LA, Li J, Shah K, Weinberg JS. Spinal Anaplastic Oligodendroglioma With Oligodendrogliomatosis: Molecular Markers and Management: Case Report. Neurosurgery. 2016 Mar; 78(3):E466-73. PMID: 26352098.
      View in: PubMed
    23. Kim DW, Barcena E, Mehta UN, Rohlfs ML, Kumar AJ, Penas-Prado M, Kim KB. Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: a case report. BMC Cancer. 2015 May 13; 15:400. PMID: 25962795.
      View in: PubMed
    24. Villarejo-Galende A, Sarandeses P, Penas-Prado M, Hernández-Laín A, Ramos A, Hernández-Martínez AC, Carro E, Ricoy JR, Hernández-Gallego J. PET-Florbetapir findings in primary cerebral amyloidoma. J Neurol. 2015; 262(4):1052-4. PMID: 25605437.
      View in: PubMed
    25. Cachia D, Wani K, Penas-Prado M, Olar A, McCutcheon IE, Benjamin RS, Armstrong TS, Gilbert MR, Aldape KD. C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma. Brain Tumor Pathol. 2015 Apr; 32(2):105-11. PMID: 25388523.
      View in: PubMed
    26. Cachia D, Prado MP, Theeler B, Hamilton J, McCutcheon I, Fuller GN. Synchronous rosette-forming glioneuronal tumor and diffuse astrocytoma with molecular characterization: a case report. Clin Neuropathol. 2014 Nov-Dec; 33(6):407-11. PMID: 24986181.
      View in: PubMed
    27. Cachia D, Singh C, Tetzlaff MT, Penas-Prado M. Middle cerebral artery territory infarct due to Cryptococcus infectionstitle: an uncommon indication for cerebrospinal fluid analysis in stroke patients. Diagn Cytopathol. 2015 Aug; 43(8):632-4. PMID: 25352313.
      View in: PubMed
    28. Penas-Prado M, Hess KR, Fisch MJ, Lagrone LW, Groves MD, Levin VA, De Groot JF, Puduvalli VK, Colman H, Volas-Redd G, Giglio P, Conrad CA, Salacz ME, Floyd JD, Loghin ME, Hsu SH, Gonzalez J, Chang EL, Woo SY, Mahajan A, Aldape KD, Yung WK, Gilbert MR. Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma. Neuro Oncol. 2015 Feb; 17(2):266-73. PMID: 25239666.
      View in: PubMed
    29. Farnia B, Allen PK, Brown PD, Khatua S, Levine NB, Li J, Penas-Prado M, Mahajan A, Ghia AJ. Clinical outcomes and patterns of failure in pineoblastoma: a 30-year, single-institution retrospective review. World Neurosurg. 2014 Dec; 82(6):1232-41. PMID: 25045788.
      View in: PubMed
    30. Ghia AJ, Chang EL, Allen PK, Mahajan A, Penas-Prado M, McCutcheon IE, Brown PD. Intracranial hemangiopericytoma: patterns of failure and the role of radiation therapy. Neurosurgery. 2013 Oct; 73(4):624-30; discussion 630-1. PMID: 23839520.
      View in: PubMed
    31. Anderson MD, Theeler BJ, Penas-Prado M, Groves MD, Yung WK. Bevacizumab use in disseminated choroid plexus papilloma. J Neurooncol. 2013 Sep; 114(2):251-3. PMID: 23761024.
      View in: PubMed
    32. Yust-Katz S, Garciarena P, Liu D, Yuan Y, Ibrahim N, Yerushalmi R, Penas-Prado M, Groves MD. Breast cancer and leptomeningeal disease (LMD): hormone receptor status influences time to development of LMD and survival from LMD diagnosis. J Neurooncol. 2013 Sep; 114(2):229-35. PMID: 23756727.
      View in: PubMed
    33. Ghia AJ, Allen PK, Mahajan A, Penas-Prado M, McCutcheon IE, Brown PD. Intracranial hemangiopericytoma and the role of radiation therapy: a population based analysis. Neurosurgery. 2013 Feb; 72(2):203-9. PMID: 23149953.
      View in: PubMed
    34. Fakhreddine MH, Mahajan A, Penas-Prado M, Weinberg J, McCutcheon IE, Puduvalli V, Brown PD. Treatment, prognostic factors, and outcomes in spinal cord astrocytomas. Neuro Oncol. 2013 Apr; 15(4):406-12. PMID: 23322747.
      View in: PubMed
    35. Cavaletti G, Cornblath DR, Merkies IS, Postma TJ, Rossi E, Frigeni B, Alberti P, Bruna J, Velasco R, Argyriou AA, Kalofonos HP, Psimaras D, Ricard D, Pace A, Galiè E, Briani C, Dalla Torre C, Faber CG, Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey D, Kerrigan S, Schenone A, Fabbri S, Valsecchi MG. The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. Ann Oncol. 2013 Feb; 24(2):454-62. PMID: 22910842.
      View in: PubMed
    36. Penas-Prado M, Armstrong TS, Gilbert MR. Glioblastoma. Handb Clin Neurol. 2012; 105:485-506. PMID: 22230514.
      View in: PubMed
    37. Sierra-Hidalgo F, Penas-Prado M, Martín-Gil L, Herreros-Rodríguez J, Hilario-Barrio A, Ruiz-Morales J. [Cerebral infarctions and leptomeningeal carcinomatosis]. Rev Neurol. 2009 Aug 1-15; 49(3):156. PMID: 19621311.
      View in: PubMed
    38. Penas-Prado M, Loghin ME. Spinal cord compression in cancer patients: review of diagnosis and treatment. Curr Oncol Rep. 2008 Jan; 10(1):78-85. PMID: 18366964.
      View in: PubMed
    39. Penas-Prado M, Gilbert MR. Molecularly targeted therapies for malignant gliomas: advances and challenges. Expert Rev Anticancer Ther. 2007 May; 7(5):641-61. PMID: 17492929.
      View in: PubMed
    40. Penas-Prado M, Martínez-Salio A, Porta-Etessam J, Villarejo-Galende A, García-Ramos R, Saiz-Díaz RA, Moreno-Ramos T. [Post-traumatic supraorbital neuralgia: a benign condition]. Rev Neurol. 2007 Jan 16-31; 44(2):89-91. PMID: 17236147.
      View in: PubMed
    41. Fernández-Miranda C, de la Peña P, Penas M, Saiz R, Gómez P, Gómez de la Cámara A. [Hyperhomocysteinemia and treatment with antiepileptic drugs. Effects of different doses of folic acid]. Med Clin (Barc). 2005 Apr 16; 124(14):521-4. PMID: 15847747.
      View in: PubMed
    42. Villarejo A, Porta-Etessam J, Camacho A, González De La Aleja J, Martínez-Salio A, Penas M. Gabapentin for painful legs and moving toes syndrome. Eur Neurol. 2004; 51(3):180-1. PMID: 15073446.
      View in: PubMed
    43. Galende AV, Camacho A, Gomez-Escalonilla C, Penas M, Juntas R, Ramos A, Esteban J. Lateral medullary infarction secondary to vertebral artery dissection presenting as a trigeminal autonomic cephalalgia. Headache. 2004 Jan; 44(1):70-4. PMID: 14979886.
      View in: PubMed
    44. González de la Aleja Tejera J, Penas Prado M, González Martínez V, Rodríguez Peña-Marín M. [Spontaneous spinal epidural hematoma]. Neurologia. 2003 Jun; 18(5):285-6. PMID: 12768518.
      View in: PubMed
    45. Villarejo-Galende A, Camacho-Salas A, Penas-Prado M, Juntas-Morales R, Gonzalez-de la Aleja J, Ramos A, Rodríguez-Vallejo A. [Spinal epidural abscess in a patient with septicaemia]. Rev Neurol. 2003 Jun 16-30; 36(12):1152-5. PMID: 12833235.
      View in: PubMed
    46. Villarejo A, Camacho A, García-Ramos R, Moreno T, Penas M, Juntas R, Ruiz J. Cholinergic-dopaminergic imbalance in Pisa syndrome. Clin Neuropharmacol. 2003 May-Jun; 26(3):119-21. PMID: 12782913.
      View in: PubMed
    47. Villarejo-Galende A, Camacho-Salas A, Penas-Prado M, García-Ramos R, Mendoza MC, Simón de las Heras R, Mateos-Beato F. [Unilateral isolated paralysis of the soft palate: a case report and a review of the literature]. Rev Neurol. 2003 Feb 15-28; 36(4):337-9. PMID: 12599130.
      View in: PubMed
    48. Martínez-Salio A, Penas M, Porta-Etessam J, Lizasoain M. [Autoimmune meningitis simulating bacterial meningitis]. Enferm Infecc Microbiol Clin. 2002 Dec; 20(10):535-6. PMID: 12433357.
      View in: PubMed
    49. Penas M, Blanco A, Villarejo A, Juntas R, Miranda P, Martínez A. [Subacute combined degeneration of the spinal cord: MR findings]. Neurologia. 2002 Oct; 17(8):447-8. PMID: 12396977.
      View in: PubMed
    50. Martínez-Salio A, Penas M, Blanco A, Miranda P, Porta-Etessam J, Posada I. [Brachial plexopathy in varicella of the adults. A case report]. Rev Neurol. 2001 Sep 16-30; 33(6):599-600. PMID: 11727250.
      View in: PubMed
    51. Penas-Prado M, Díaz-Guzmán J, Jiménez-Huerta I, Juntas-Morales R, Villarejo-Galende A, Díez-Torres I. [Gradenigo syndrome as the form of presentation of nasopharyngeal carcinoma]. Rev Neurol. 2001 Apr 1-15; 32(7):638-40. PMID: 11391492.
      View in: PubMed
    52. A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma. Journal of Neuro-Oncology. 1-8.
    53. NRG oncology RTOG 0625. Journal of Neuro-Oncology. 131:193-199.
    54. Spinal Anaplastic Oligodendroglioma with Oligodendrogliomatosis. Neurosurgery. 78:E466-E473.
    55. Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma. Pituitary. 1-7.
    56. Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy. BMC Cancer. 15.
    57. Neuralgia supraorbitaria. Revista de Neurologia. 44:383.
    PENAS-PRADO's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description